Lantern Pharma demonstrates withZeta.ai AI co-scientist platform; no financial data disclosed

Lantern Pharma Inc.

Live demo of withZeta.ai, a multi-agentic AI platform for rare cancer drug discovery and clinical design.
Presentation discussed platform capabilities, commercial architecture, rare cancer market opportunity, and competitive positioning.
Outlined near-term revenue strategy and growth roadmap for the withZeta.ai platform.
Replay of the demonstration available at provided Zoom link; presentation furnished as Exhibit 99.1.
No specific financial or operational metrics were provided in the filing or exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.